Clinical Trial Update: Mechanistic Clinical Trial of PCSK9 Inhibition for AAA [EARLY_Phase 1]

View source ↗

Summary

An early-phase mechanistic trial is investigating PCSK9 inhibition as a potential treatment for abdominal aortic aneurysm, with the study currently NOT_YET_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• PCSK9 inhibitor (unspecified)

Snippet

Sponsor: University of Pennsylvania | Conditions: Abdominal Aortic Aneurysm | EARLY_Phase 1 | Status: NOT_YET_RECRUITING